The Karolinska Institute has announced that the 2026 Nobel Prize in Medicine will be awarded to Karl Deisseroth of Stanford University, Peter Hegemann of Humboldt University in Berlin, and Georg Nagel of the University of Würzburg. Their collective research led to the creation of optogenetics, a method enabling scientists to activate or deactivate specific nerve cells using light beams.
Per Svenningsson, chair of the Nobel Committee for Medicine, highlighted the transformative potential of this technology. He noted that optogenetics offers unprecedented opportunities to map brain activity, providing a level of precision in studying living brains that was previously unimaginable. This capability is crucial for advancing our understanding of nervous system functions and various neurological disorders.
The award also underscores the power of interdisciplinary convergence within biology. While optogenetics is now a cornerstone of neuroscience, its foundational discoveries originated from microbiology research. Specifically, the insights came from studying how single-celled algae detect and respond to light.
In the late 1990s, Peter Hegemann began investigating the mechanisms behind light detection in the alga Chlamydomonas. Previous studies had identified an “eye spot” on the organism’s surface, which contains the light-sensitive molecule retinal. Using microelectrodes, Hegemann measured the electrical signals generated by the alga and found that it could produce an impulse approximately 0.5 milliseconds after light exposure. This reaction is 20 times faster than the human eye, which requires at least 10 milliseconds to process light.
Hegemann hypothesized that the alga’s light detection relied on a simpler process than that of humans. In the early 1990s, he proposed that the eye spots contained a protein acting as both a light detector and a responder, likely functioning as an ion channel. This idea was controversial at the time, as no known ion channels could respond to light independently.
To validate his theory, Hegemann attempted to isolate the light-sensitive proteins from the eye spot, but they proved unstable outside their natural environment. The breakthrough came when Japanese researchers sequenced the complete DNA of Chlamydomonas, allowing Hegemann’s team to identify two genes responsible for creating proteins with the characteristics of a light-sensing channel.
Georg Nagel then took on the task of verifying these genes’ functions. He introduced copies of each gene into separate groups of frog eggs, which began producing the respective proteins that localized to the cell membranes. Upon illuminating the eggs, Nagel confirmed that the proteins indeed responded to light, marking a pivotal step toward the development of optogenetics.
Leave a Reply